Impact of biomass fuel smoke on respiratory health of children under 15 years old in Madagascar.


Journal

Respiratory medicine and research
ISSN: 2590-0412
Titre abrégé: Respir Med Res
Pays: France
ID NLM: 101746324

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 18 07 2022
revised: 15 12 2022
accepted: 02 01 2023
medline: 9 6 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

Children exposed to biomass used in households are at risk to develop diseases or respiratory symptoms. In Madagascar more than 95% of households use it daily. The main objective is to study the impact of chronic exposure to biomass on respiratory health of children under 15 years old in Madagascar. Descriptive cross-sectional study conducted with questionnaires among urban and rural population of Antananarivo and Mahajanga provinces between 2016 and 2017. Variables were collected: number of hours spent in kitchen per day, respiratory symptoms and spirometric data. Categorized symptoms score and exposure index expressing chronic exposure to biomass were analyzed with multinomial logistic regression models. Of the 661 children included in the analysis, 27.7% had 1 respiratory symptom and 29.3% had 2 or more respiratory symptoms. Moderate exposure index (aOR=1.57; CI95%=[1.30-1.89]; p<0.001) and high exposure index (aOR=1.76; CI95%=[1.39-2.24]; p<0.001) were significantly associated with 1 respiratory symptom, adjusted with provinces, household members and visitors smoking, perceived discomfort related to air pollution and birthweight. Exposure index was not significantly associated with an increased risk of having 2 or more respiratory symptoms (p = 0.754). Respiratory symptoms were associated with exposure to biomass, living in coastal areas, birthweight, tobacco and perceived discomfort related to air pollution. Recommendations and actions must be implemented in order to improve respiratory health related to biomass among children.

Sections du résumé

BACKGROUND BACKGROUND
Children exposed to biomass used in households are at risk to develop diseases or respiratory symptoms. In Madagascar more than 95% of households use it daily. The main objective is to study the impact of chronic exposure to biomass on respiratory health of children under 15 years old in Madagascar.
METHODS METHODS
Descriptive cross-sectional study conducted with questionnaires among urban and rural population of Antananarivo and Mahajanga provinces between 2016 and 2017. Variables were collected: number of hours spent in kitchen per day, respiratory symptoms and spirometric data. Categorized symptoms score and exposure index expressing chronic exposure to biomass were analyzed with multinomial logistic regression models.
RESULTS RESULTS
Of the 661 children included in the analysis, 27.7% had 1 respiratory symptom and 29.3% had 2 or more respiratory symptoms. Moderate exposure index (aOR=1.57; CI95%=[1.30-1.89]; p<0.001) and high exposure index (aOR=1.76; CI95%=[1.39-2.24]; p<0.001) were significantly associated with 1 respiratory symptom, adjusted with provinces, household members and visitors smoking, perceived discomfort related to air pollution and birthweight. Exposure index was not significantly associated with an increased risk of having 2 or more respiratory symptoms (p = 0.754).
CONCLUSION CONCLUSIONS
Respiratory symptoms were associated with exposure to biomass, living in coastal areas, birthweight, tobacco and perceived discomfort related to air pollution. Recommendations and actions must be implemented in order to improve respiratory health related to biomass among children.

Identifiants

pubmed: 37043971
pii: S2590-0412(23)00001-6
doi: 10.1016/j.resmer.2023.100989
pii:
doi:

Substances chimiques

Smoke 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100989

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Nolwenn Jestin-Guyon (N)

Inserm, Bordeaux Population Health Research Center, Team: EPICENE, UMR1219, Bordeaux University, 146 Rue Léo Saignat, Bordeaux 33076 CEDEX, France. Electronic address: nolwenn.jestin-guyon@u-bordeaux.fr.

El Hassane Ouaalaya (EH)

Inserm, Bordeaux Population Health Research Center, Team: EPICENE, UMR1219, Bordeaux University, 146 Rue Léo Saignat, Bordeaux 33076 CEDEX, France; High Institute of Nursing Professions and Health Techniques, ISPITS, Agadir, Morocco.

Michel Tiaray Harison (MT)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Kiady Ravahatra (K)

University-Hospital of Anosiala, Antananarivo, Madagascar.

Jocelyn Rakotomizao (J)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Rondro Nirina Raharimanana (RN)

University-Hospital of Fenoarivo, Fenoarivo, Madagascar.

Joelson Lovaniaina Rakotoson (JL)

University-Hospital of Fianarantsoa, Fianarantsoa, Madagascar.

Jobeline Rajaoarifetra (J)

University-Hospital of Toamasina, Toamasina, Madagascar.

Jean-Claude Andriamihaja Rakotoarisoa (JA)

University-Hospital of Ravoahangy, Antananarivo, Madagascar.

Giannie Rasamimanana (G)

University-Hospital of Mahajanga, Mahajanga, Madagascar.

Charlin Randriamananjara (C)

University-Hospital of Antananarivo, Antananarivo, Madagascar.

Bakoly Ravalison (B)

University-Hospital of Antananarivo, Antananarivo, Madagascar.

Ange Andrianarisoa (A)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Andrianaivo Ralison (A)

University-Hospital of Mahajanga, Mahajanga, Madagascar.

Raoelina Andriambololona (R)

National Institute of Nuclear Sciences and Techniques (INSTN), Antananarivo, Madagascar.

Denis Charpin (D)

University-Hospital of Marseille, Marseille, France.

Jean De Dieu Marie Rakotomanga (JDM)

National Institute of Public Health and Community Health (INSPC), Antananarivo, Madagascar.

Iantsoatiana Davidson Rakotondrabe (ID)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Marie Odette Rasoafaranirina (MO)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Zisler Michael Rakotondravola (ZM)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Aglaé Rakotoson (A)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Jean Robert Rakotondriaka (JR)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Anjara Nandimbiniaina (A)

University-Hospital of Befelatanana, Antananarivo, Madagascar.

Orelys Ratsirahonana (O)

University-Hospital of Antananarivo, Antananarivo, Madagascar.

Patricia Feno (P)

University-Hospital of Antananarivo, Antananarivo, Madagascar.

Mampionona Razafindramboa (M)

Espace Santé de Parasol, Villeneuve sur Lot, France.

Brigitte Rahoelina (B)

Medical Office, Saint Denis, Reunion.

Jean-Marie Tschopp (JM)

Geneva Faculty of Medecine, Geneva, Switzerland.

Martial Coutaz (M)

Valais Hospital, Geneva, Switzerland.

Stéphane Garrone (S)

Medical Office, Monthey, Switzerland.

Pierre L'Her (P)

Soutien Pneumologique International (SPI), Paris, France.

Chantal Raherison-Semjen (C)

Inserm, Bordeaux Population Health Research Center, Team: EPICENE, UMR1219, Bordeaux University, 146 Rue Léo Saignat, Bordeaux 33076 CEDEX, France; University-Hospital of Pointe-à-Pitre, Pointe-à-Pitre, Guadeloupe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH